DSM-5 Personality Disorders in Adults with Autism
1 other identifier
observational
102
1 country
1
Brief Summary
Rationale: Self-report measures are frequently used for research and clinical assessments of adults with autism spectrum disorder (ASD). However, there has been little research examining agreement between self-report and informant-report in this population. Reliable self-report measures are essential for conducting research with and providing high quality clinical services for adults with autism spectrum disorder. Objective: This study aims to examine the usefulness of self-report of DSM-5-TR PD traits in adults with ASD compared to informant-reports by administering the self-report screening measure of the Structured Clinical Interview for DSM-5 Screening Personality Questionnaire (SCID-5-SPQ).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Mar 2024
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2024
CompletedFirst Submitted
Initial submission to the registry
December 5, 2024
CompletedFirst Posted
Study publicly available on registry
December 10, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 30, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
September 30, 2025
CompletedDecember 10, 2024
May 1, 2024
1.6 years
December 5, 2024
December 5, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Score SCID-5-PD
The main study parameters are the item scores on the SCID-5-PD.
1 day
Study Arms (2)
1
Adults with autism spectrum disorder
2
The relative of the adult with autism spectrum disorder
Interventions
Screening questionnaire
Eligibility Criteria
Adult males and females (age ≥ 18 years), clinically diagnosed with ASD by a psychologist or a psychiatrist, without intellectual disability, and their informants. ASD participants will be recruited from Sarr Autism Rotterdam, the Netherlands, specialized in psychodiagnostic assessment and treatment for children, adolescents, and adults with ASD. Sarr is part of Parnassia Groep, multisite mental health institute in the Netherlands.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Parnassia Groeplead
Study Sites (1)
Sarr - Parnassia Groep Antes
Rotterdam, Netherlands
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- CROSS SECTIONAL
- Target Duration
- 1 Day
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 5, 2024
First Posted
December 10, 2024
Study Start
March 1, 2024
Primary Completion
September 30, 2025
Study Completion
September 30, 2025
Last Updated
December 10, 2024
Record last verified: 2024-05
Data Sharing
- IPD Sharing
- Will not share